Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) EBITDA (2023 - 2025)

Historic EBITDA for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to -$3.6 million.

  • SeaStar Medical Holding's EBITDA rose 1968.13% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.9 million, marking a year-over-year increase of 1304.02%. This contributed to the annual value of -$17.8 million for FY2024, which is 2555.95% down from last year.
  • Latest data reveals that SeaStar Medical Holding reported EBITDA of -$3.6 million as of Q3 2025, which was up 1968.13% from -$1.8 million recorded in Q2 2025.
  • SeaStar Medical Holding's EBITDA's 5-year high stood at -$1.8 million during Q2 2025, with a 5-year trough of -$4.8 million in Q4 2024.
  • In the last 3 years, SeaStar Medical Holding's EBITDA had a median value of -$3.8 million in 2025 and averaged -$3.7 million.
  • As far as peak fluctuations go, SeaStar Medical Holding's EBITDA tumbled by 6230.85% in 2024, and later soared by 6239.02% in 2025.
  • SeaStar Medical Holding's EBITDA (Quarter) stood at -$2.9 million in 2023, then crashed by 62.31% to -$4.8 million in 2024, then grew by 24.92% to -$3.6 million in 2025.
  • Its EBITDA was -$3.6 million in Q3 2025, compared to -$1.8 million in Q2 2025 and -$3.8 million in Q1 2025.